View Clinical Trial (Medical Research Study)

Effect on Primary Dysmenorrhea - NCT00909857-27103(Clinical Trial 295671)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Winston-Salem
State:  
NC
Zip Code: 27103
Conditions: Primary Dysmenorrhea
Purpose: To investigate the potential benefits of a new oral contraceptive (SH T00658ID) on alleviating complaints of dysmenorrhea associated with oral contraceptive use.
Study summary:
Criteria: Inclusion Criteria: - Otherwise healthy female subjects requesting contraception and suffering from primary dysmenorrhea with a sum score for dysmenorrheic pain3 intensity of >/= 8 over 2 baseline cycles documented by a prospective self-rated sum pain score - Age: 14 - 50 years (inclusive; smokers must not be older than 30 years) at the time point of informed consent - Normal cervical smear not requiring further follow-up (a cervical smear has to be taken at the screening visit, or a normal result has to be available that was documented within the last 6 months before the screening visit) - Women with cyclic menstrual bleeding, defined by a cycle length between 25 and 35 days and no amenorrheic cycles or cycles without withdrawal bleeding during the last 3 months prior to visit 1. - Able to tolerate ibuprofen and willing to use only Ibuprofen supplied for the study. Exclusion Criteria: - Pregnancy or lactation (delivery, abortion, or lactation within three cycles before the start of treatment) - Obesity: body mass index (BMI) > 32 kg/m2 - Hypersensitivity to any of the study drug ingredients - Any diseases or conditions that might interfere with the conduct of the study or the interpretation of the results - Presence or a history of venous or arterial thrombotic / thromboembolic events (e.g. deep venous thrombosis, pulmonary embolism, myocardial infarction) or of a cerebrovascular accident, including prodromi (e.g. transient ischemic attack, angina pectoris), and conditions that could increase the risk of suffering from any of the above mentioned disorders, e.g. a family history indicating a hereditary predisposition Undiagnosed abnormal genital bleeding - Abuse of alcohol, drugs, or medicines (e.g. laxatives) - Other contraceptive methods: - Sterilization - Oral, vaginal or transdermal hormonal contraception during treatment - Intra-uterine devices (IUD) with or without hormone release still in place within 30 days of visit 1 - Simultaneous participation in another clinical trial or participation in another clinical trial prior to study entry that might have an impact on the study objectives at the discretion of the investigator - Major surgery scheduled for the study period
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: June 22, 2010
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.